GE HealthCare named to 2025 Fortune World's Most Admired Companies™ list

1/29/25 7:30:00 AM ET

Medical Electronics

Health Care

Get the next $GEHC alert in real time by email

This is GE HealthCare's first appearance on the list, marking a significant milestone as an independent company

GE HealthCare (NASDAQ:GEHC) has been named to 2025 Fortune World's Most Admired Companies™ list. The company has been recognized across several categories including the quality of management, products and services, innovation, value as a long-term investment, financial soundness, talent acquisition and retention, community and environmental responsibility, global business, and use of corporate assets.

Being named to Fortune World's Most Admired Companies™ list for the first time, two years after becoming an independent company, is a testament to GE HealthCare's progress against its precision care strategy across disease states, enabling colleagues to deliver innovations that improve clinical workflows and help clinicians make more precise diagnoses and improve patient outcomes.

"This recognition is a testament to the dedication of our 51,000 global colleagues who help deliver our precision care strategy to best serve our patients and customers," said Peter Arduini, President and CEO at GE HealthCare. "Our entrepreneurial and inclusive culture ensures that the broad perspectives and expertise of our teams continue to build our 125-year legacy of innovation, advance our purpose-driven strategy and help make a meaningful impact on healthcare worldwide."

A company's score must rank in the top half of its industry survey to be listed. The ranking is considered the "gold standard" for employee-centric companies, highlighting employers who have created an exemplary work environment. For more information and to view the complete list of companies, visit: http://fortune.com/worlds-most-admired-companies/.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient's journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

From Fortune, ©2025 Fortune Media IP Limited. All rights reserved. Used under license. Fortune is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of GE HealthCare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250129762134/en/

GE HealthCare Media Contact:

Jennifer Fox

(414) 530-3027

[email protected]

Get the next $GEHC alert in real time by email

Recent Analyst Ratings for

$GEHC

Date	Price Target	Rating	Analyst
1/8/2025	$95.00 → $103.00	Hold → Buy	Jefferies
9/26/2024	$84.00 → $74.00	Neutral → Sell	UBS
9/18/2024	$100.00	Neutral → Buy	BTIG Research
9/9/2024	$90.00	Neutral	JP Morgan
8/6/2024	$100.00	Buy	Stifel
5/30/2024	$87.00	Neutral	Goldman
2/15/2024	$100.00	Buy	HSBC Securities
2/12/2024	$66.00 → $88.00	Sell → Neutral	UBS

More analyst ratings

GE HealthCare named to 2025 Fortune World's Most Admired Companies™ list

Chat with this insight

Recent Analyst Ratings for
$GEHC

$GEHC
Financials

Live finance-specific insights

GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025

GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth

GE HealthCare reports third quarter 2024 financial results

$GEHC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

CEO, Imaging Rott Roland exercised 13,275 shares at a strike of $40.40, covered exercise/tax liability with 9,698 shares and sold $309,339 worth of shares (3,577 units at $86.48) (SEC Form 4)

CEO, AVS Rackliffe Philip sold $78,867 worth of shares (900 units at $87.63), decreasing direct ownership by 7% to 12,715 units (SEC Form 4)

Ch. Supply Chain & Serv. Ofc. Stacherski Kenneth R. covered exercise/tax liability with 11,028 shares, decreasing direct ownership by 29% to 27,055 units (SEC Form 4)

$GEHC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

$GEHC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

GE HealthCare upgraded by Jefferies with a new price target

GE HealthCare downgraded by UBS with a new price target

GE HealthCare upgraded by BTIG Research with a new price target

$GEHC
Press Releases

Fastest customizable press release news feed in the world